A new concept for anti-counterfeiting security films that utilize the humidity from human breath to reveal a QR code on color-tunable one-dimensional (1D) PC films is presented. The 1D PC film was fabricated on a transparent polyethylene terephthalate (PET) substrate via sequential alternate layer deposition of photo-crosslinkable poly(2-vinylnaphthalene-co-benzophenone acrylate) (P(2VN-co-BPA)) and quaternized poly(4-vinylpyridine-co-benzophenone acrylate) (P(4VP-co-BPA)) (P4QP-51%). The films exhibited remarkable color transitions with reliable reversibility and reproducibility. Films placed on a black background exhibited the full visible spectrum color in a high humidity environment. Additionally, films placed on a white background displayed three different composite colors, including yellow, magenta, and cyan. These films with vivid color transitions in a high humidity environment can be applied as anti-counterfeiting films. A hidden QR code was also laser printed on the initial PC film to enhance the film's anti-counterfeiting security capabilities. These colorimetric 1D PC films can be used as anti-counterfeiting labels and for information storage.
18 February 2021 in ACS Applied Materials & Interfaces
The spectral modification of sunlight from less efficient green (500–600 nm) to more efficient red (600–700 nm) by light-converting fluorescent dyes has been widely studied for enhancing the microalgal biomass productivity. In particular, deep-red (650–700 nm) photons, which are mainly used by photosynthetic pigments of microalgae for photosynthesis, play a key role in promoting microalgal growth. In this study, we have synthesized three different deep-red emitting diketopyrrolopyrrole (DPP) dyes and utilized two of them to fabricate light-converting films for microalgal cultivation. The introduction of free-rotatable triphenylamine (TPA) moieties into DPP dyes enabled them to exhibit excellent solid state emission via aggregation-induced emission (AIE). As a result, cultured microalgae showed different biomass and lipid productivity according to the degree of increase in the photosynthetic photon flux density (PPFD) of the light-converting films. In detail, strong deep-red emission of the light-converting film prepared using dye E2 increased the total fatty acid methyl ester (FAME) content of microalgae up to 62.4%. In contrast, the weak deep-red emission of the light-converting film based on dye M2 resulted in an enhancement of only 28.8%. These results show that the deep-red emitting AIE-DPPs could potentially be applied in light-converting film materials for accelerating the mass production of microalgae.
Objectives: To evaluate the efficacy and safety of tamsulosin and Hachimijiogan or Ryutanshakanto in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.Methods: A prospective, randomized, double‐blind method was used to determine the efficacy and safety of the combination or placebo at baseline and 4, 8, and 12 weeks of study. The International Prostate Symptom Score, quality of life index, complete voiding diary, and National Institutes of Health‐Chronic Prostatitis Symptom Index were studied. Uroflowmetery and postvoid residual urine volume were measured and compared. Laboratory tests including prostate‐specific antigen were performed.Results: In all groups, International Prostate Symptom Score and quality of life showed improvement, but no significant differences were shown among the groups. Prostate volume increased after treatment, and uroflowmetric parameters showed improvements after treatment without significance among the three groups. The total score of the National Institutes of Health‐Chronic Prostatitis Symptom Index showed a significant improvement in all groups, without significant differences among the groups. Only the pain sub‐score of the National Institutes of Health‐Chronic Prostatitis Symptom Index showed a significant decrease in the tamsulosin with Ryutanshakanto group compared to the control group. A total of 11 adverse reactions occurred, but they were mild and not related to the study drugs.Conclusion: Ryutanshakanto can provide pain relief in patients with chronic prostatitis and chronic pelvic pain syndrome. If more research is conducted, Hachimijiogan and Ryutanshakanto may be applied as add‐on treatments in patients with storage symptoms with alpha‐blocker monotherapy.